May 14, 2021 9:15am EDT Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 15, 2021 7:00am EDT Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences
Apr 05, 2021 7:00am EDT Recro Strengthens Business Development Team to Drive Customer Growth and Diversification